MCOS: Myopia Control With Orthokeratology Contact Lenses in Spain

Sponsor
Menicon Co., Ltd. (Industry)
Overall Status
Completed
CT.gov ID
NCT04806763
Collaborator
Universidad Europea de Madrid (Other), Aston University (Other), Clinica novovision (Other)
69
2
36

Study Details

Study Description

Brief Summary

The purpose of this prospective study is to assess the efficacy, safety and patient-reported outcomes of the Menicon Z Night orthokeratolgy contact lens for reducing myopia progression in children.

Condition or Disease Intervention/Treatment Phase
  • Device: Menicon Z Night
  • Device: Control
N/A

Detailed Description

The purpose of this prospective study is to assess the efficacy, safety and patient-reported outcomes of the Menicon Z Night orthokeratolgy contact lens for reducing myopia progression in children in comparison with a group of distance, single-vision glasses over a 2-year period. Efficacy was evaluated by assessing differences in the axial length between groups. Safety was evaluated by comparing the incidence of adverse events between groups. Differences between groups in patient-reported outcomes were evaluated using a questionnaire that assessed vision-related quality-of-life measures.

Study Design

Study Type:
Interventional
Actual Enrollment :
69 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective, controlled, longitudinalProspective, controlled, longitudinal
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Myopia Control With Orthokeratology Contact Lenses in Spain
Actual Study Start Date :
Mar 1, 2007
Actual Primary Completion Date :
Mar 1, 2010
Actual Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Menicon Z Night

The experimental group is allocated to wear Menicon Z Night orthokeratology contact lenses for two years

Device: Menicon Z Night
To assess the use of Menicon Z Night contact lenses for reducing myopia progression in children

Active Comparator: Glasses

The active comparator includes a group that was allocated to wear distance, single-vision glasses for two years

Device: Control
Distance, single-vision glasses were used as control

Outcome Measures

Primary Outcome Measures

  1. Axial length [Two years]

    To compare axial length growth between white children with myopia wearing Menicon Z Night orthokeratology contact lenses and distance single-vision glasses. Measurements of axial length (in millimeters) were taken with the Zeiss IOLMaster (Carl Zeiss Jena GmbH, Jena, Germany). Three separate measurements of axial length were recorded per subject and per visit, and a mean obtained.

Secondary Outcome Measures

  1. Adverse events [Two years]

    To compare the incidence of adverse events between white children with myopia wearing Menicon Z Night orthokeratology contact lenses and distance single-vision glasses. Adverse events were classified into serious, significant, or non-significant. Recurrences of the same adverse event(s) in the same or fellow eye at any of the subsequent study visits were classified as separate events; bilateral events will be counted as two separate events. The incidence of adverse events was calculated as a percentage of eyes per annum.

  2. Patient-reported outcomes [Two years]

    To compare vision-related quality-of-life measures between children wearing Menicon Z Night orthokeratology contact lenses and distance single-vision glasses. The pediatric refractive error profile survey was used to compare patient-reported outcomes in terms of the vision-specific quality of life between children in the Menicon Z Night and control groups. The survey consists of 26 statements scored from 1 (poor quality of life) to 5 (good quality of life), then scaled from 0 to 100 by subtracting 1 from the raw score of each question and multiplying by 25. The mean score of all items was calculated as the overall score. The survey includes 11 scales: overall vision, near vision, far distance vision, symptoms, appearance, satisfaction, activities, academics, handling, peer perception, and overall score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Be 6 to 12 years of age, both ages inclusive

  • A low-to-moderate level of myopia (between -0.75 and -4.00 D) and of astigmatism (≤ 1.00 D)

  • Neophyte contact lens wearer

  • Be successfully fitted with spectacles or orthokeratology contact lenses

  • Be able to achieve, through spherical refraction correction, a logMAR visual acuity of 0.8 or better in each eye

  • Be willing and able to follow the subject instructions and to meet the protocol-specified schedule of follow-up visits

  • White European ethnicity

Exclusion Criteria:
  • Systemic or ocular disease affecting ocular health

  • Use of any systemic or topical medications that could affect ocular physiology or contact lens performance

  • Any lid or anterior segment abnormalities for which contact lens wear could be contraindicated

  • CCLRU grade ≥ 2 for any given anterior segment ocular clinical signs

  • Aphakic, amblyopic, and atopic individuals

  • Refractive astigmatism ≥ ½ spherical refraction

  • Previous contact lens wear

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Menicon Co., Ltd.
  • Universidad Europea de Madrid
  • Aston University
  • Clinica novovision

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Menicon Co., Ltd.
ClinicalTrials.gov Identifier:
NCT04806763
Other Study ID Numbers:
  • MCOS
First Posted:
Mar 19, 2021
Last Update Posted:
Mar 26, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 26, 2021